Question Bank › Small reported base, oversized already-contracte

Small reported base, oversized already-contracted forward commitments

Calls Tested
1,498
Answered YES
59
Hit Rate
3.9%
rare by design

Accuray Incorporated (ARAY) — this company's answers

NO on the Q4 2016 call 2016-08-17 B
The model's full reasoning — Q4 2016 call → NO我们根据指令，只使用提供的文本。问题问管理是否描述了未来业务，即对手方已承诺的（合同、订单、中标项目、承诺量、积压或扩展），且相对于当前报告的业务水平是大的，转换在一年内开始或继续。管理层的措辞必须传达（a）已确定并承诺，（b）不成比例，以及（c）近期且大部分尚未反映在报告结果中。 检查文本：管理层讨论了创纪录的积压订单（4.06亿美元）、创纪录的第四季度总订单（9540万美元）、NHS多系统订单（公司历史上最大单笔订单）、多个Radixact参考站点安装、Onrad在中国获批但预计订单在第二季度后。然而，关键点：这些承诺是否已实现？NHS订单已记录在第四季度总订单中（实际已计入，所以是已实现的，不是未来转化）。积压订单是已承诺的，但积压订单是常规业务，管理层说积压增长8%至4.06亿美元，这是报告数字的一部分，不是未来业务。管理层提到第一台Radixact已安装，但商业化尚未完全启动，参考站点是安装，不是订单？可能这些是内部部署以监控性能，不一定是客户订单。Onrad获批但订单预计在Q3，这是未来的潜在订单，尚未实现。管理层还提到一个美国多系统订单没有在Q4关闭，但客户现在预计在2017财年下达多个单独订单，第一个已进入积压（Q1）。但那是延迟，不是新的承诺。 问题问管理是否描述了“未来业务”即“对手方已经承诺”，且相对当前水平很大，转化在一年内。管理层提到了积压订单增长，但积压订单是已经确认的订单，属于当前报告的一部分（但它们是未来收入）。不过，问题要求“large relative to current reported level”，且“conversion into actual revenue expected to begin or continue within roughly coming year”，并且“today's numbers understate the business already captured”。积压订单是已经捕获的业务，但管理层是否将其描述为大的？管理层说“backlog is perhaps the best indicator of the dollars Accuray will ultimately record to product revenue”，并且增长8%至4.06亿美元，但这并不是一个即将产生的新重大业务，而是正常的积压。问题中“committed volumes, backlog”可以算，但需要“large relative to current reported level”。4.06亿美元积压相对于年收入3.99亿美元是大的，但这是正常的，因为积压是持续存在的。管理层没有特别强调这是未来不成比例的增长，而是说“we have now eclipsed the $400 million mark for the first time”，但这是记录。然而，积压是已经确认的订单，所以它确实是承诺的业务，但它是常规的，因为公司一直有积压。问题说“NO if the committed business is routine in size for this company or is ordinary backlog worked off at the usual pace.” 这里的积压增长8%可能不是巨大的，而且积压是逐步转化为收入的。管理层没有说这个积压将导致近期收入的大幅增长，而是说2017财年收入增长3-5%，产品收入增长6-9%。所以积压支持这种增长，但这不是“偏离常规”的。 管理层还提到了“record fourth quarter gross orders”和“largest order in company's history” NHS订单，但该订单已经计入第四季度订单，属于已报告结果的一部分，不是未来业务。管理层提到未来将会有Radixact和Onrad订单，但这些都是预计，不是已承诺的。管理层提到“the first of these systems has already gone into backlog in Q1”是指美国多系统订单，但那是之前提到延迟的订单，现在分拆成多个，第一个已进入积压，但这是处理延迟，不是新的承诺。 因此，管理层没有明确描述一个大的、已承诺的未来业务，将在一年内转化而不在当前数字中。相反，他们给出的是指导，基于预期订单和产品推出。所以答案应为NO。 需要严格使用文本。文本中管理层没有说“我们已获得X合同，价值Y，将带来大量收入”之类的。NHS订单是已经记录的，不是未来的。所以答案是NO。

← Back to the full ARAY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe FUTURE BUSINESS THAT COUNTERPARTIES HAVE ALREADY COMMITTED TO THE COMPANY — signed contracts, firm orders, awarded programs, committed volumes, backlog, or agreed expansions, in whatever form fits the industry — that management itself presents as LARGE RELATIVE TO THE COMPANY'S CURRENT REPORTED LEVEL OF BUSINESS, with conversion into actual revenue or activity expected to begin or continue within roughly the coming year? Answer YES when management's own words convey ALL of: (a) the forward business is already secured — decided and committed by the counterparty, not pipeline, bids, negotiations, or hoped-for demand; (b) management conveys the disproportion in its own framing — comparing it to current revenue or activity, calling it record or unprecedented for the company, or describing the expansion, hiring, or preparation now required to deliver it; and (c) the contribution is near-dated and mostly still ahead of the results just reported, so today's numbers understate the business already captured. Answer NO if the forward story rests on demand strength, market opportunity, pipeline, or deals still being negotiated. NO if the committed business is routine in size for this company or is ordinary backlog worked off at the usual pace. NO if conversion is distant, undated, or contingent on approvals, financing, or decisions not yet made. NO if management is chiefly explaining delays or cancellations of previously committed business. NO if the disproportion appears only in an analyst's model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AIP Arteris, Inc. Q1 2024 2024-05-04 A
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
HSAI Hesai Group Q4 2023 2024-03-12 D
EFXT Enerflex Ltd. Q3 2023 2023-11-09 C+
MAC The Macerich Company Q3 2023 2023-10-31 D
EVLV Evolv Technologies Holdings, Inc. Q2 2023 2023-08-10 B+
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
OSK Oshkosh Corporation Q2 2023 2023-08-01 B+
NXT Nextracker Inc. Q1 2024 2023-07-28 C+
USAP Universal Stainless & Alloy Products, In Q2 2023 2023-07-26 B
DLR Digital Realty Trust, Inc. Q4 2022 2023-02-16 C+
ROAD Construction Partners, Inc. Q1 2023 2023-02-10 A
FLNC Fluence Energy, Inc. Q1 2023 2023-02-09 B+
ACLS Axcelis Technologies, Inc. Q4 2022 2023-02-09 A
SMRT SmartRent, Inc. Q3 2022 2022-11-13 B
PFMT Performant Financial Corporation Q3 2022 2022-11-12 C
BEEM Beam Global Q3 2022 2022-11-10 C+
TT Trane Technologies plc Q3 2022 2022-11-02 A
PLOW Douglas Dynamics, Inc. Q3 2022 2022-11-01 B+
FSLR First Solar, Inc. Q3 2022 2022-10-28 C+
RDI Reading International, Inc. Q2 2022 2022-08-14 C
CMAX CareMax, Inc. Q2 2022 2022-08-13 C
EVGO EVgo, Inc. Q2 2022 2022-08-09 C+
UUUU Energy Fuels Inc. Q2 2022 2022-08-09 C
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
NSIT Insight Enterprises, Inc. Q1 2022 2022-05-08 A
KTCC Key Tronic Corporation Q3 2022 2022-05-07 C
JCI Johnson Controls International plc Q2 2022 2022-05-04 C
VSH Vishay Intertechnology, Inc. Q1 2022 2022-05-03 B
SILC Silicom Ltd. Q1 2022 2022-04-30 B+
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
VALN Valneva SE Q4 2021 2022-03-24 C
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
CDMO Avid Bioservices, Inc. Q3 2022 2022-03-08 B+
CMT Core Molding Technologies, Inc. Q4 2021 2022-03-08 C+
STN Stantec Inc. Q4 2021 2022-02-27 A
AMAT Applied Materials, Inc. Q1 2022 2022-02-16 B+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
PLUS ePlus inc. Q3 2022 2022-02-03 C+
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
PNR Pentair plc Q3 2021 2021-10-26 C+
GDS GDS Holdings Limited Q2 2021 2021-08-17 C+
AGYS Agilysys, Inc. Q1 2022 2021-07-27 A
DOV Dover Corporation Q2 2021 2021-07-20 B+
BKYI BIO-key International, Inc. Q3 2018 2018-11-15 D
TPIC TPI Composites, Inc. Q3 2018 2018-11-11 C
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
FTK Flotek Industries, Inc. Q2 2018 2018-08-08 F
NPO EnPro Industries, Inc. Q2 2018 2018-08-02 C
MVIS MicroVision, Inc. Q2 2018 2018-07-31 D
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
CG The Carlyle Group Inc. Q1 2018 2018-05-04 B
CPK Chesapeake Utilities Corporation Q3 2017 2017-11-10 A
LEA Lear Corporation Q2 2017 2017-07-26 B+
VSAT Viasat, Inc. Q4 2017 2017-05-23 C+
TGEN Tecogen Inc. Q2 2016 2016-08-10 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+

How the model reasoned

VALN · Q4 2021 → YESThe question is about whether management describes future business that counterparties have already committed to, that's large relative to current business, and expected soon. NO The transcript shows management referencing existing purchase agreements and specific deliveries (e.g., 24.3 million doses in Q2-Q3 2022), but the overall 2022 revenue guidance explicitly includes both existing agreements and anticipated new contracts to be concluded over the coming months. The "up to" structure and 2022-2023 timeline indicate that not all volume is firmly committed and secured today, with some elements still in negotiation or pipeline. Management does not frame the full guidance range as already-decided and disproportionate in a way that excludes future deals; instead, it presents the range as incorporating both secured and expected additional contracts.
EVLV · Q2 2023 → YESThe question is about whether management describes future business that counterparties have already committed to, that's large relative to current business, with conversion expected soon. YES The transcript explicitly presents RPO of $198.3 million as a record high, up 145% year-over-year and 23% sequentially, and frames it as committed future revenue from existing contracts. Management contrasts this with current quarterly revenue of $19.8 million and ARR of $54 million, stating 2023 ARR will more than double from $34 million at the end of 2022 to $70-72 million. They note subscriptions growing to 4,500 by year-end from 3,386, with RPO expected to support this growth.
HSAI · Q4 2023 → YESThe question is about whether management describes future business that counterparties have already committed to, that's large relative to current business, with conversion expected soon. NO The transcript describes forward business through customer forecasts, order book additions, and planned SOP expansions for 2024, but does not present any committed, secured contracts or programs as "large relative to current reported business" with the required disproportion in management's own framing. Instead, it frames these as forecast-based growth and pipeline expansions, with explicit distinctions between awarded programs and RFI/RFQ opportunities.

More from the question bank

Repeat expansion inside the base while new lPhysical throughput records at the operatingConstraint-side candorFree option on their own operationsThe economics improved before the volume arrQuestions aim low, answers land highAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.